Although a mediated settlement is already on the table awaiting court approval, the U.S. Court of Appeals for the Fifth Circuit breathed new life into Cassava Sciences Inc.’s fight to stave off a ...

Labcorp Holdings Inc. appears to be on an acquisition spree. It has agreed to buy the Prenatal Health testing business of ...

Hitting statistical significance and proof of concept in phase II for bipolar mania, Rapport Therapeutics Inc. is moving to ...

Beating other PD-1 therapies to the finish line, GSK plc’s Jemperli (dostarlimab) secured accelerated approval from the U.S.

New blood-based biomarker tests that detect Alzheimer’s before symptoms appear are poised to transform the clinical landscape by catching the disease when controlling for risk factors is known to have ...

Abbott Laboratories received CE mark certification for the Cologuard Plus, a stool-based DNA test designed to detect both colorectal cancer and advanced precancerous lesions. The test was developed by ...

Chengdu Kangnuoxing Biopharma Inc. and Keymed Biosciences Co. Ltd. have reported new protein/nucleic acid degraders comprising an E3 ubiquitin ligase-binding moiety covalently linked to a signal ...

The Indian government issued a new drug pricing order that would impose a 30% cap on supply chain margins for 137 cancer ...

Life sciences investors are raising billions of dollars in fresh capital, with a cluster of new funds and acquisition ...

Putting the February complete response letter firmly in the rearview mirror, Disc Medicine Inc. is gearing up for a second go at the U.S. FDA, this time on the back of positive top-line data from the ...

Eyepoint Inc. is cutting its workforce by about 53% and prioritizing its late-stage program for Duravyu (vorolanib intravitreal insert, EYP-1901) in diabetic macular edema, following a disappointing ...

Researchers from Monument Therapeutics Ltd. presented preclinical pharmacokinetic and pharmacodynamic data supporting phase I ...